🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Scotiabank maintains $6.50 target on NorthWest Healthcare

EditorLina Guerrero
Published 10/02/2024, 03:26 PM
NWHUF
-

On Wednesday, Scotiabank maintained its Sector Perform rating and C$6.50 price target for NorthWest Healthcare Properties REIT (OTC:NWHUF), traded on the Toronto Stock Exchange under the ticker NWH-U:CN and on the OTC market as NWHUF. The firm's analysis indicates a positive outlook following recent debt refinancings by the healthcare real estate investment trust.

The analyst from Scotiabank noted significant progress in addressing the company's debt obligations, particularly those maturing in 2025. NorthWest Healthcare has been proactive in managing its debt, as evidenced by the sale of its U.K. portfolio announced in August 2024, which has contributed to a more stable financial position. This sale, along with a recent Federal Reserve policy shift, has been beneficial for the REIT, which is known for its high leverage and exposure to variable-rate debt.

NorthWest Healthcare's latest announcement detailed further debt refinancing actions, leaving only C$340 million of debt to be addressed for 2025. This remaining amount includes C$215 million in property-level debt and C$125 million in Convertible Debentures. The company plans to redeem the debentures using proceeds from asset sales, effectively resolving concerns over its 2025 debt maturities.

At the beginning of the year, debt maturing in 2024-2025 constituted 60% of NorthWest Healthcare's total debt, with C$1.6 billion due in 2025. Following the U.K. portfolio sale and the recent refinancing update, the analyst estimates that 2025 debt maturities now represent approximately 10% of the total debt. Most of this is property-level debt, which the company expects to renew in the normal course of business.

In light of these developments, Scotiabank has reiterated its C$6.50 price target for NorthWest Healthcare Properties REIT. The firm's outlook reflects confidence in the REIT's ability to manage its debt portfolio and maintain financial stability.

In other recent news, NorthWest Healthcare Properties REIT continues to garner attention from investors and stakeholders due to its strategic initiatives aimed at bolstering its market position.

BMO Capital has maintained its Market Perform rating of the company, acknowledging the company's efforts over the past year that have led to increased operational stability and reduced risk. However, the firm has also noted that NorthWest Healthcare needs to make further progress to consistently outperform its peers in the Canadian listed property sector.

Despite these positive developments, the Market Perform rating and the price target of Cdn$5.25 remain unchanged. BMO Capital views the company's recent undertakings as a step in the right direction but suggests that NorthWest Healthcare Properties REIT needs to continue evolving to achieve a lasting advantage over competitors in its sector. The firm's current assessment indicates a neutral stance, with no immediate change to the investment outlook.

InvestingPro Insights

To complement Scotiabank's analysis of NorthWest Healthcare Properties REIT, recent data from InvestingPro offers additional context. The REIT's market capitalization stands at $1.07 billion USD, reflecting its significant presence in the healthcare real estate sector. Despite the positive outlook on debt management, InvestingPro Tips highlight that the company is not profitable over the last twelve months, with a negative P/E ratio of -59.66.

However, aligning with Scotiabank's observations on the company's progress, InvestingPro data shows a strong return over the last three months, with a 26.37% price total return. This performance is complemented by a 28.75% return over the past six months, indicating positive momentum that may be linked to the company's debt refinancing efforts and strategic asset sales.

Notably, NorthWest Healthcare Properties REIT has maintained dividend payments for 15 consecutive years, according to InvestingPro Tips. The current dividend yield is 6.32%, which may be attractive to income-focused investors, although it's worth noting that dividend growth has been negative at -56.42% in the last twelve months.

For investors seeking a more comprehensive analysis, InvestingPro offers 8 additional tips for NorthWest Healthcare Properties REIT, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.